161 related articles for article (PubMed ID: 16198612)
1. Botulinum toxin-A injections for spastic toe clawing.
Lim EC; Ong BK; Seet RC
Parkinsonism Relat Disord; 2006 Jan; 12(1):43-7. PubMed ID: 16198612
[TBL] [Abstract][Full Text] [Related]
2. Botulinum toxin-A injections via electrical motor point stimulation to treat writer's cramp: pilot study.
Lim EC; Quek AM; Seet RC
Neurol Neurophysiol Neurosci; 2006 Jun; ():4. PubMed ID: 17260081
[TBL] [Abstract][Full Text] [Related]
3. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
Wissel J; Entner T
Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048
[TBL] [Abstract][Full Text] [Related]
4. Comparative impact of 2 botulinum toxin injection techniques for elbow flexor hypertonia.
Mayer NH; Whyte J; Wannstedt G; Ellis CA
Arch Phys Med Rehabil; 2008 May; 89(5):982-7. PubMed ID: 18452749
[TBL] [Abstract][Full Text] [Related]
5. A randomized controlled trial to compare two botulinum toxin injection techniques on the functional improvement of the leg of children with cerebral palsy.
Kaishou Xu ; Tiebin Yan ; Jianning Mai
Clin Rehabil; 2009 Sep; 23(9):800-11. PubMed ID: 19482892
[TBL] [Abstract][Full Text] [Related]
6. Botulinum toxin type A for upper limb spasticity following stroke: an open-label study with individualised, flexible injection regimens.
Slawek J; Bogucki A; Reclawowicz D
Neurol Sci; 2005 Apr; 26(1):32-9. PubMed ID: 15877185
[TBL] [Abstract][Full Text] [Related]
7. Repeated treatments with botulinum toxin type a produce sustained decreases in the limitations associated with focal upper-limb poststroke spasticity for caregivers and patients.
Elovic EP; Brashear A; Kaelin D; Liu J; Millis SR; Barron R; Turkel C
Arch Phys Med Rehabil; 2008 May; 89(5):799-806. PubMed ID: 18452724
[TBL] [Abstract][Full Text] [Related]
8. A randomised, double-blind, dose-ranging study to evaluate efficacy and safety of three doses of botulinum toxin type A (Botox) for the treatment of spastic foot.
Mancini F; Sandrini G; Moglia A; Nappi G; Pacchetti C
Neurol Sci; 2005 Apr; 26(1):26-31. PubMed ID: 15877184
[TBL] [Abstract][Full Text] [Related]
9. [Botulinum toxin injections and hypertonic upper limbs. Which functional results?].
Ferrapie AL; Vieillart A; Saint-Cast Y; Menei P; Richard I
Ann Readapt Med Phys; 2005 May; 48(4):172-9. PubMed ID: 15848259
[TBL] [Abstract][Full Text] [Related]
10. Local botulinum toxin type A injections in the treatment of spastic toes.
Suputtitada A
Am J Phys Med Rehabil; 2002 Oct; 81(10):770-5. PubMed ID: 12362118
[TBL] [Abstract][Full Text] [Related]
11. Dynamic splinting after treatment with botulinum toxin type-A: a randomized controlled pilot study.
Lai JM; Francisco GE; Willis FB
Adv Ther; 2009 Feb; 26(2):241-8. PubMed ID: 19194671
[TBL] [Abstract][Full Text] [Related]
12. Botulinum toxin dilution and endplate targeting in spasticity: a double-blind controlled study.
Gracies JM; Lugassy M; Weisz DJ; Vecchio M; Flanagan S; Simpson DM
Arch Phys Med Rehabil; 2009 Jan; 90(1):9-16.e2. PubMed ID: 19154823
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of focal upper limb spasticity with botulinum toxin after stroke. Interest of an individual approach].
Luauté J; Landrault E; Jacquin-Courtois S; Mertens P; Rode G; Boisson D
Ann Readapt Med Phys; 2004 Oct; 47(8):555-62. PubMed ID: 15465160
[TBL] [Abstract][Full Text] [Related]
14. Upper limb function after botulinum toxin A treatment in cerebral palsy: two years follow-up of six cases.
Sätilä H; Kotamäki A; Koivikko M; Autti-Rämö I
Pediatr Rehabil; 2006; 9(3):247-58. PubMed ID: 17050402
[TBL] [Abstract][Full Text] [Related]
15. Nerve stimulation boosts botulinum toxin action in spasticity.
Frasson E; Priori A; Ruzzante B; Didonè G; Bertolasi L
Mov Disord; 2005 May; 20(5):624-9. PubMed ID: 15726575
[TBL] [Abstract][Full Text] [Related]
16. Functional outcomes of intramuscular botulinum toxin type a and occupational therapy in the upper limbs of children with cerebral palsy: a randomized controlled trial.
Wallen M; O'Flaherty SJ; Waugh MC
Arch Phys Med Rehabil; 2007 Jan; 88(1):1-10. PubMed ID: 17207668
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of botulinum toxin A in the treatment of spasticity of the lower extremities in adults - preliminary report.
Opara J; Hordyńska E; Swoboda A
Ortop Traumatol Rehabil; 2007; 9(3):277-85. PubMed ID: 17721426
[TBL] [Abstract][Full Text] [Related]
18. Botulinum toxin A in the treatment of hemiplegic spastic foot drop--clinical and functional outcomes.
Chua KS; Kong KH; Lui YC
Singapore Med J; 2000 May; 41(5):209-13. PubMed ID: 11063169
[TBL] [Abstract][Full Text] [Related]
19. Repeated botulinum toxin injections can improve mobility in patients with spinal cord lesions.
Catz A; Barkol H; Steinberg F; Ronen J; Bluvshtein V; Keren O
Eura Medicophys; 2007 Sep; 43(3):319-25. PubMed ID: 17525702
[TBL] [Abstract][Full Text] [Related]
20. Factors affecting the health-related quality of life of patients with cervical dystonia and the impact of botulinum toxin type A injections.
Slawek J; Friedman A; Potulska A; Krystkowiak P; Gervais C; Banach M; Ochudlo S; Budrewicz S; Reclawowicz D; Rynkowski M; Opala G
Funct Neurol; 2007; 22(2):95-100. PubMed ID: 17637212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]